EVMNEvommune, Inc.

CSNew York Stock Exchange (XNYS)·USD

Identity

Security key: 15018
Ticker: EVMN
Type: CS — Common Stock
Exchange: New York Stock Exchange(XNYS)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 2025-11-06
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: EVMN

Detail

Enriched 2026-08-14 20:47

Market cap: $512,444,635.56
Shares outstanding (class): 36,292,113
Shares outstanding (weighted): 36,292,113
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 48
Location: PALO ALTO, CA
Homepage: https://www.evommune.com
Description: Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Market cap and share counts drift.

Funds holding this security

60 funds · 61 positions · $80.85M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST	—	$21.61M	1.36%	940,119 NS	FIGI
JPMorgan Small Cap Growth Fund JPMorgan Trust II	—	$14.15M	0.65%	615,520 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$8.34M	0.07%	362,730 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$7.33M	0.00%	318,897 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$5.66M	0.05%	246,092 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$5.56M	0.01%	241,659 NS	FIGI
JPMorgan Small Cap Blend Fund JPMorgan Trust I	—	$4.57M	0.32%	198,713 NS	FIGI
T. Rowe Price Integrated U.S. Small-Cap Growth … T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.	—	$3.88M	0.05%	168,800 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$2.87M	0.00%	124,870 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$1.02M	0.01%	44,265 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$941.9K	0.01%	40,972 NS	FIGI
T. Rowe Price Integrated U.S. Small-Mid Cap Cor… T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.	—	$645.1K	0.05%	28,062 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$607.3K	0.05%	26,415 NS	FIGI
T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II	—	$402.3K	0.04%	17,500 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$390.2K	0.01%	16,974 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKEREVMN
FIGI_COMPOSITEBBG00Y79N887
FIGI_SHARE_CLASSBBG00Y79N8B3
CIK0002044725
ISINUS30054Y1073
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: SIC 2834 indicates pharmaceutical preparations, so the security is an equity in the healthcare sector.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.